+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Metopimazine"

Gastroparesis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Gastroparesis - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • February 2024
  • 144 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Metopimazine is a type of gastrointestinal drug used to treat nausea and vomiting. It is a dopamine antagonist, meaning it works by blocking the action of dopamine, a chemical messenger in the brain that can cause nausea and vomiting. Metopimazine is available in both oral and injectable forms, and is often used in combination with other antiemetic drugs. It is commonly prescribed for the treatment of nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery. It is also used to treat motion sickness, vertigo, and other conditions. Metopimazine is available in generic and brand-name formulations, and is sold by a variety of pharmaceutical companies. Some of the companies that produce metopimazine include Pfizer, Novartis, Sanofi, Merck, and GlaxoSmithKline. Show Less Read more